Nemolizumab Approved for AD, Prurigo Nodularis in Europe ...Middle East

Medscape - News
Nemolizumab Approved for AD, Prurigo Nodularis in Europe
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Nemolizumab Approved for AD, Prurigo Nodularis in Europe )

Also on site :